Editorial: The advances in proteomics and targeted therapy of malignant brain tumours

Anjing Chen; Zhenyi An

doi:10.3389/fonc.2023.1195847

Editorial: The advances in proteomics and targeted therapy of malignant brain tumours

Front Oncol. 2023 Apr 25:13:1195847. doi: 10.3389/fonc.2023.1195847. eCollection 2023.

Authors

Anjing Chen^{1

2}, Zhenyi An³

Affiliations

¹ Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, China.
² Jinan Microecological Biomedicine Shandong Laboratory, Shandong Key Laboratory of Brain Function Remodeling, Jinan, China.
³ Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.

No abstract available

Keywords: advances; glioma; malignant brain tumours; proteomics; targeted therapy.

Publication types

Editorial

Grants and funding

This work was supported by the Special Foundation for Taishan Scholars (tsqn201909173), the Department of Science & Technology of Shandong Province (ZR2022ZD36), and the Research Project of Jinan Microecological Biomedicine Shandong Laboratory (JNL-2023007C).